


Ask a doctor about a prescription for Flunarizinum Vzf
Flunarizinum
Flunarizinum WZF contains flunarizine, which belongs to a group of so-called calcium antagonists, preventing blood vessel constriction.
Flunarizinum WZF is used:
Before starting to take Flunarizinum WZF, discuss it with your doctor.
Warning:Do not increase the dose of the medicine if you suspect a migraine attack.
Flunarizinum WZF does not stop a migraine attack.
Tell your doctor if:
During treatment with Flunarizinum WZF, especially long-term, you should regularly visit your doctor and follow their recommendations regarding the duration of treatment - see section
In elderly patients, there is a risk of movement disorders, stiffness, inability to sit, tremors, so these patients should strictly follow their doctor's recommendations regarding dosing - see also section 3 of the leaflet "How to take Flunarizinum WZF".
If these symptoms occur, the patient should stop taking the medicine and consult their doctor immediately.
Flunarizinum WZF should not be used in children and adolescents due to concerns about safety in this age group.
Tell your doctor about all medicines you are taking, have recently taken, or plan to take.
Take the medicine orally, preferably immediately after dinner, to avoid stomach irritation. Swallow the tablets whole, with water - see section 3. "How to take Flunarizinum WZF".
Do not drink alcohol while taking Flunarizinum WZF, as excessive sedation and drowsiness may occur.
If you are pregnant, think you may be pregnant, or plan to have a baby, ask your doctor for advice before taking this medicine.
Do not take Flunarizinum WZF during pregnancy or breastfeeding.
Flunarizinum WZF may affect your ability to drive or use machines, especially at the beginning of treatment. Do not perform these activities until the disturbances have resolved.
If you have been diagnosed with an intolerance to some sugars, consult your doctor before taking the medicine.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor.
Initial doses:
Maintenance doses (continuation of treatment):
If, after 2 months of taking the medicine to prevent migraines, no improvement is observed, stop taking the medicine and consult your doctor.
Take the same doses as for migraine prevention.
If, after 1 month of taking the medicine for chronic dizziness or after 2 months of preventing episodic dizziness, no improvement is observed, stop taking the medicine and consult your doctor.
Flunarizinum WZF is not indicated for use in children and adolescents (under 18 years of age)
After taking a higher dose of the medicine than recommended, sedation and a feeling of weakness, powerlessness, and helplessness (asthenia) may occur. After taking a large number of Flunarizinum WZF tablets, symptoms such as excessive sedation, excitement, and rapid heartbeat (palpitations) may occur. If these symptoms occur, consult your doctor.
If you miss a dose of Flunarizinum WZF, take it as soon as possible. If it is almost time for the next dose, skip the missed dose and take the next one according to the schedule. Do not take a double dose to make up for the missed dose.
If you have any further questions about taking this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, Flunarizinum WZF can cause side effects, although not everybody gets them.
Common (less than 1 in 10 people):
Uncommon (less than 1 in 100 people):
If you experience any side effects, including any not listed in this leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Store in a temperature below 25°C.
Store in the outer packaging to protect from light.
Do not use this medicine after the expiry date stated on the blister and carton. The expiry date refers to the last day of the month.
The inscription on the packaging after the abbreviation EXP means the expiry date, and after the abbreviation Lot/LOT means the batch number.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Flunarizinum WZF - white or almost white tablets, flat on both sides, with beveled edges.
The carton contains 30 tablets in blisters made of aluminum/PVC.
Marketing authorization holder
Zakłady Farmaceutyczne POLPHARMA S.A.
ul. Pelplińska 19, 83-200 Starogard Gdański
phone: +48 22 364 61 01
Manufacturer
Zakłady Farmaceutyczne POLPHARMA S.A.
Production Plant in Nowa Dęba
ul. Metalowca 2, 39-460 Nowa Dęba
Date of last revision of the leaflet:December 2024
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Flunarizinum Vzf – subject to medical assessment and local rules.